Financials Dr. Wu Skincare Co., Ltd.

Equities

6523

TW0006523004

Other Specialty Retailers

End-of-day quote Taipei Exchange 23:00:00 08/05/2024 BST 5-day change 1st Jan Change
179 TWD 0.00% Intraday chart for Dr. Wu Skincare Co., Ltd. +2.58% +17.76%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,973 4,572 3,018 4,527 4,662 6,847
Enterprise Value (EV) 1 1,496 2,987 1,448 3,138 3,312 5,577
P/E ratio 120 x 23.8 x 4.58 x 15.3 x 13.7 x 16.1 x
Yield 0.68% 13.7% 5.97% 11.2% 7.73% 5.26%
Capitalization / Revenue 3.09 x 4.51 x 3.95 x 4.09 x 5.03 x 6.02 x
EV / Revenue 1.55 x 2.95 x 1.89 x 2.84 x 3.57 x 4.9 x
EV / EBITDA 16.4 x 11.9 x 5.88 x 8.18 x 8.78 x 11.3 x
EV / FCF 11.7 x 23.1 x 30.4 x 5.96 x 16.3 x 19.2 x
FCF Yield 8.54% 4.33% 3.29% 16.8% 6.14% 5.21%
Price to Book 1.74 x 2.43 x 1.51 x 2.95 x 3.05 x 4.64 x
Nbr of stocks (in thousands) 45,048 45,048 45,048 45,048 45,048 45,048
Reference price 2 66.00 101.5 67.00 100.5 103.5 152.0
Announcement Date 11/03/19 25/03/20 18/03/21 18/03/22 16/03/23 21/03/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 963 1,014 764.6 1,106 926.8 1,137
EBITDA 1 90.99 252 246.3 383.5 377.2 494.2
EBIT 1 70.81 235.4 237.4 376.4 372.6 490
Operating Margin 7.35% 23.21% 31.04% 34.03% 40.21% 43.09%
Earnings before Tax (EBT) 1 63.25 228.2 793.1 372 424.1 525.8
Net income 1 24.84 191.8 661.1 296.2 340 424.7
Net margin 2.58% 18.91% 86.46% 26.78% 36.68% 37.35%
EPS 2 0.5500 4.258 14.63 6.570 7.540 9.420
Free Cash Flow 1 127.8 129.3 47.68 526.4 203.3 290.7
FCF margin 13.27% 12.75% 6.24% 47.6% 21.94% 25.56%
FCF Conversion (EBITDA) 140.46% 51.33% 19.36% 137.28% 53.91% 58.82%
FCF Conversion (Net income) 514.56% 67.43% 7.21% 177.71% 59.8% 68.44%
Dividend per Share 2 0.4500 13.86 4.000 11.22 8.000 8.000
Announcement Date 11/03/19 25/03/20 18/03/21 18/03/22 16/03/23 21/03/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales 1 331.4 - 257.4 165.8 225 278.6
EBITDA - - - - - -
EBIT 1 122.4 - 113.6 57.27 82.7 119.1
Operating Margin 36.94% - 44.12% 34.54% 36.76% 42.75%
Earnings before Tax (EBT) 1 119.4 - 138.4 70.8 96.23 118.6
Net income 1 104.2 - 110.9 52.54 81.73 94.8
Net margin 31.42% - 43.08% 31.69% 36.33% 34.03%
EPS 2 2.310 1.840 2.460 1.170 1.810 2.110
Dividend per Share - - - - - -
Announcement Date 11/11/21 09/03/22 11/05/22 12/08/22 02/11/22 16/03/23
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 1,477 1,585 1,570 1,389 1,350 1,270
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 128 129 47.7 526 203 291
ROE (net income / shareholders' equity) 1.39% 10.7% 34.1% 16.8% 22.2% 28.3%
ROA (Net income/ Total Assets) 2.24% 7.42% 6.87% 11.5% 12.9% 17.3%
Assets 1 1,109 2,584 9,620 2,579 2,638 2,461
Book Value Per Share 2 38.00 41.80 44.40 34.10 33.90 32.70
Cash Flow per Share 2 11.20 13.90 15.80 22.80 14.50 10.50
Capex 1 6.91 19.8 1.78 3.26 1.59 2.95
Capex / Sales 0.72% 1.96% 0.23% 0.29% 0.17% 0.26%
Announcement Date 11/03/19 25/03/20 18/03/21 18/03/22 16/03/23 21/03/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 6523 Stock
  4. Financials Dr. Wu Skincare Co., Ltd.